Medtronic PLC (MDT)vsZimmer Biomet Holdings Inc (ZBH)
MDT
Medtronic PLC
$87.89
+1.51%
HEALTHCARE · Cap: $110.62B
ZBH
Zimmer Biomet Holdings Inc
$87.64
+1.53%
HEALTHCARE · Cap: $17.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 331% more annual revenue ($35.48B vs $8.23B). MDT leads profitability with a 13.0% profit margin vs 8.6%. ZBH appears more attractively valued with a PEG of 0.60. ZBH earns a higher WallStSmart Score of 59/100 (C).
MDT
Buy56
out of 100
Grade: C
ZBH
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-255.7%
Fair Value
$24.34
Current Price
$87.89
$63.55 premium
Margin of Safety
-296.1%
Fair Value
$24.14
Current Price
$87.64
$63.50 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.3B in free cash flow
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Earnings declined 11.8%
ROE of 5.6% — below average capital efficiency
Weak financial health signals
Earnings declined 40.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.
Bull Case : ZBH
The strongest argument for ZBH centers on Price/Book, PEG Ratio. Revenue growth of 10.9% demonstrates continued momentum. PEG of 0.60 suggests the stock is reasonably priced for its growth.
Bear Case : MDT
The primary concerns for MDT are EPS Growth.
Bear Case : ZBH
The primary concerns for ZBH are Return on Equity, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
MDT carries more volatility with a beta of 0.73 — expect wider price swings.
ZBH is growing revenue faster at 10.9% — sustainability is the question.
MDT generates stronger free cash flow (2.3B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZBH scores higher overall (59/100 vs 56/100) and 10.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Zimmer Biomet Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?